Navigation Links
Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
Date:5/16/2008

Single Molecule with Dual Mechanism May Offer Novel Approach to Blood

Pressure Management

NEW ORLEANS, May 16 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that PS433540, its first-in-class Dual Acting Receptor Antagonist (DARA), showed statistically significant blood pressure reductions in a Phase 2a study in patients with mild to moderate hypertension. PS433540 is being developed as a potential treatment for both hypertension and diabetic nephropathy and is a novel blood pressure product candidate that possesses two validated mechanisms of action in a single molecule. The data will be presented today at the Recent and Late Breaking Clinical Trials Session at the American Society of Hypertension (ASH) Twenty-Third Annual Scientific Meeting and Exposition in New Orleans.

The Phase 2a study met its primary endpoint by showing a statistically significant reduction in mean 24-hour systolic ambulatory blood pressure over placebo. The study also showed statistically significant improvements over placebo in mean 24-hour diastolic ambulatory blood pressure as well as seated blood pressure. In this double-blind, placebo-controlled study, patients treated with 200 mg of PS433540 once daily experienced a 12/9mmHg drop in mean 24-hour systolic and diastolic blood pressure and those treated with 500 mg experienced a 15/10mmHg drop in mean 24-hour systolic and diastolic blood pressure. These reductions were highly statistically significant vs. placebo (P<0.001). Mean seated office systolic and diastolic blood pressure, the typical blood pressure measure, was also evaluated, with observed blood pressure drops of 17/11mmHg with the 200 mg dose and 17/10mmHg with the 500 mg dose (P<0.001 vs. placebo).

Once-daily treatment with 200 or 500 mg of PS433540 was well tolerated. Most of the adverse events reported were mild o
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
3. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
4. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
5. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
6. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
7. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
8. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
9. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
10. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
11. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Increasing unnecessary regulations on drug plans could inflict higher ... medications through a managed drug plan, according to a ... Analysis Senior Fellow Devon Herrick. "The ... helps makes medications affordable," says Herrick. "Blatant protectionism through ... protections, but more often than not they are designed ...
(Date:4/20/2015)... -- Stand Up To Cancer (SU2C) and the American Cancer ... Team to attack the number one cancer killer in America, ... American Association for Cancer Research (AACR), Scientific Partner to SU2C. ... the United States will be diagnosed with ... from it, making lung cancer the leading cause of cancer ...
(Date:4/20/2015)... Eli Lilly and Company (NYSE: LLY ... statistically superior to placebo in the treatment of patients ... proportion of patients achieving an ACR 20 response. ACR ... percent reduction in disease signs and symptoms as defined ... the 24-week, Phase 3 study, titled SPIRIT-P1, patients who ...
Breaking Medicine Technology:Restrictive Drug Plan Regulations Will Hurt Patients 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 3New SU2C-American Cancer Society Lung Cancer Dream Team Announced 4New SU2C-American Cancer Society Lung Cancer Dream Team Announced 5New SU2C-American Cancer Society Lung Cancer Dream Team Announced 6Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... Chilcott plc (Nasdaq: WCRX ) today announced a ... certain selling shareholders. The selling shareholders include funds ... Morgan Partners (advised by CCMP Capital) and Thomas H. ... of the Company,s senior management. The offering is ...
... Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company ... inflammation and disorders of the central nervous system, today ... Thursday, November 19, 2009 to discuss the Company,s third ... A. Demopulos, M.D., Chairman and CEO of Omeros, will ...
Cached Medicine Technology:Warner Chilcott Announces Secondary Equity Offering 2Warner Chilcott Announces Secondary Equity Offering 3Warner Chilcott Announces Secondary Equity Offering 4Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19 2
(Date:4/20/2015)... (PRWEB) April 20, 2015 Saint Joseph Regional ... 15 Top Health Systems by Truven Health Analytics, a leading ... quality of healthcare. SJRMC has been recognized by Truven Health ... the past four years. , According to Truven Health Analytics' ... Health Systems, in matchups with their peers, set the standard ...
(Date:4/20/2015)... 20, 2015 The American Association for ... and Safety Improvement as the 2015 winner of the ... association’s Annual Meeting, April 18, in Las Vegas, Nevada. ... team, patient safety can be dramatically improved,” said Peter ... CEO. “Northwestern Medicine and its Academy for Quality and ...
(Date:4/20/2015)... Rolling Meadows, IL (PRWEB) April 20, 2015 ... of Mutare Inc., has secured nationally-renowned Gastroenterologist Lawrence ... Medical Officer. , Dr. Kosinski brings a ... knowledge and vision to the Mutare Health ... solutions for improved communication, collaboration, and quality of ...
(Date:4/20/2015)... Lake City, Utah (PRWEB) April 20, 2015 ... End of Employer-Provided Health Insurance: Why It’s Good for ... 30, 2015. , Paul Zane Pilzer and Rick Lindquist ... of Employer-Provided Health Insurance: Why It’s Good for You ... to our nation’s employer health insurance woes - employer-funded ...
(Date:4/20/2015)... Advance Home Care Supply understands ... many customers would prefer not to share with others. As ... discreet delivery method allowing customers to order the products and ... without fear of a neighbor or passerby knowing what the ... now on all orders and no minimum order limit is ...
Breaking Medicine News(10 mins):Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 2Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 3Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 3Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3
... the San Francisco Zoo had knowingly imported parakeets with a ... human interaction //. ,While the disease is not ... virus which causes psittacine beak and feather disease could pose ... bird's immune system causing abnormal feather growth and beak deformities. ...
... by scientists to clarify with the suspected case //. ... substance for testing it with the suspected virus in the ... it has been imported from Australia and stored in vials, ... suits are engaged to deal with the dangerous substance. ...
... is major problem in the quake affected areas of Indonesia. ... contact //with the bacteria Clostridium tetani. It is otherwise ... resulting in stiffness of the jaw. If not treated properly ... recent survey it has already killed 18 earthquake survivors in ...
... outbreak of malarial attack has made people to be feared and ... spread //. This non-endemic malarial attack has not been spread through ... mosquito (female anopheles) in Bahamas. ,In Exuma, a large ... to be known by the authorities later. The Haiti country is ...
... have warned of another outbreak of bird flu in Maharashtra ... culled// in the first episode of the dreaded virus outbreak ... bird flu in the Nandurbar and Jalgaon regions, giving a ... ,If experts of the technical committee set up by ...
... different dimension to eating disorder which seems to have ... during childhood and the formative years can lead to ... into an eating disorder in women, suggesting that the ... and separation anxiety. ,Dr. Alfonso Troisi and ...
Cached Medicine News:Health News:Experts Warn of Bird Flu Recurrence in Maharashtra 2
... The Strep B OIA test ... streptococcal antigen directly from cervical or ... If culture results are unknown at ... STREP B OIA offers physicians additional ...
... delivers excellent sensitivity and specificity for the diagnosis ... test that provides an answer in 6 minutes. ... provide improved patient care with a test that ... out what value we bring to your daily ...
... and nerve block procedures, Cadwells disposable ... a precisely machined Trocar (beveled) tip ... 61-cm (24-in) lead wire. Needle is ... use only. A starter kit includes ...
Shielding's new Surgical Drop Away / Flex Back Apron offers top of the shoulder velcro flaps for an adjustable fit. Features elastic back panels for added comfort and support. For quick removal apron...
Medicine Products: